Viewing Study NCT06015503


Ignite Creation Date: 2025-12-24 @ 7:12 PM
Ignite Modification Date: 2025-12-25 @ 4:48 PM
Study NCT ID: NCT06015503
Status: RECRUITING
Last Update Posted: 2025-04-03
First Post: 2023-08-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase Ⅱ Study Assessing the Safety and Efficacy of PLB1004 in EGFR ex20ins Mutation Patients With Advanced and Metastatic Non-small Cell Lung Cancer(NSCLC)
Sponsor: Avistone Biotechnology Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module